Kinnate Biopharma Price History

KNTEDelisted Stock  USD 2.96  0.27  8.36%   
If you're considering investing in Kinnate Stock, it is important to understand the factors that can impact its price. As of today, the current price of Kinnate Biopharma stands at 2.96, as last reported on the 25th of November, with the highest price reaching 3.25 and the lowest price hitting 2.95 during the day. We have found twenty-four technical indicators for Kinnate Biopharma, which you can use to evaluate the volatility of the firm. Please verify Kinnate Biopharma's Mean Deviation of 4.52, risk adjusted performance of 0.0046, and Standard Deviation of 5.59 to check out if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Kinnate Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
KNTE
Based on monthly moving average Kinnate Biopharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Kinnate Biopharma by adding Kinnate Biopharma to a well-diversified portfolio.

Kinnate Biopharma Stock Price History Chart

There are several ways to analyze Kinnate Stock price data. The simplest method is using a basic Kinnate candlestick price chart, which shows Kinnate Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Kinnate Stock Price History Data

The price series of Kinnate Biopharma for the period between Tue, Aug 27, 2024 and Mon, Nov 25, 2024 has a statistical range of 1.97 with a coefficient of variation of 14.64. The daily prices for the period are spread out with arithmetic mean of 3.35. The median price for the last 90 days is 3.23.
OpenHighLowCloseVolume
11/25/2024
 3.23  3.25  2.95  2.96 
07/24/2023 3.23  3.25  2.95  2.96  157,096 
07/21/2023 3.15  3.24  3.03  3.21  195,807 
07/20/2023 3.22  3.24  3.15  3.15  112,199 
07/19/2023 3.21  3.31  3.16  3.23  203,183 
07/18/2023 3.07  3.28  3.07  3.20  135,039 
07/17/2023 3.08  3.18  3.01  3.07  186,840 
07/14/2023 3.21  3.21  2.99  3.07  246,637 
07/13/2023 3.31  3.36  3.22  3.23  132,829 
07/12/2023 3.28  3.37  3.17  3.31  186,900 
07/11/2023 3.06  3.21  3.00  3.17  270,024 
07/10/2023 2.99  3.16  2.99  3.05  216,425 
07/07/2023 3.02  3.07  2.95  2.99  193,104 
07/06/2023 3.10  3.10  2.90  3.02  267,312 
07/05/2023 2.99  3.16  2.97  3.15  221,444 
07/03/2023 3.08  3.08  2.93  3.01  204,375 
06/30/2023 3.33  3.33  3.00  3.03  376,687 
06/29/2023 3.37  3.49  3.00  3.22  350,366 
06/28/2023 3.38  3.44  3.28  3.36  116,425 
06/27/2023 3.33  3.50  3.21  3.41  241,074 
06/26/2023 3.21  3.36  3.15  3.26  357,633 
06/23/2023 3.10  3.24  2.99  3.17  3,248,656 
06/22/2023 3.17  3.23  3.06  3.10  326,499 
06/21/2023 3.21  3.23  2.95  3.14  293,727 
06/20/2023 3.40  3.40  3.09  3.20  531,577 
06/16/2023 3.38  3.56  3.22  3.40  727,363 
06/15/2023 3.15  3.42  3.02  3.34  474,016 
06/14/2023 3.34  3.35  3.07  3.16  326,789 
06/13/2023 3.49  3.53  3.21  3.36  523,200 
06/12/2023 3.42  3.56  3.31  3.48  312,477 
06/09/2023 3.73  3.73  3.37  3.41  315,187 
06/08/2023 3.96  4.00  3.69  3.73  458,565 
06/07/2023 4.14  4.29  3.97  3.99  310,615 
06/06/2023 4.00  4.18  3.87  4.14  356,481 
06/05/2023 4.28  4.28  3.88  3.94  334,723 
06/02/2023 4.31  4.40  4.14  4.24  334,856 
06/01/2023 4.25  4.50  4.00  4.30  568,421 
05/31/2023 3.73  4.33  3.70  4.30  842,477 
05/30/2023 3.78  3.84  3.57  3.78  231,739 
05/26/2023 3.84  4.01  3.58  3.73  214,974 
05/25/2023 3.97  3.97  3.68  3.85  198,209 
05/24/2023 4.12  4.12  3.88  3.96  280,920 
05/23/2023 4.05  4.35  4.05  4.18  333,161 
05/22/2023 3.97  4.24  3.86  4.04  367,582 
05/19/2023 3.79  4.07  3.74  4.00  287,891 
05/18/2023 4.05  4.15  3.53  3.68  567,210 
05/17/2023 4.22  4.34  3.89  4.05  447,744 
05/16/2023 4.28  4.37  4.01  4.08  447,429 
05/15/2023 3.85  4.45  3.81  4.27  545,529 
05/12/2023 3.55  3.97  3.20  3.77  544,453 
05/11/2023 3.74  4.00  3.48  3.58  1,328,642 
05/10/2023 3.40  3.56  3.16  3.48  706,579 
05/09/2023 3.19  3.40  3.06  3.34  984,923 
05/08/2023 2.94  3.11  2.80  3.10  2,837,309 
05/05/2023 2.73  2.93  2.67  2.87  1,912,293 
05/04/2023 3.01  3.04  2.45  2.63  2,160,457 
05/03/2023 3.00  3.07  2.72  2.91  853,627 
05/02/2023 2.70  2.86  2.53  2.85  582,157 
05/01/2023 2.55  2.74  2.48  2.65  1,431,045 
04/28/2023 2.52  2.65  2.45  2.53  634,607 
04/27/2023 2.34  2.58  2.34  2.51  364,838 

About Kinnate Biopharma Stock history

Kinnate Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Kinnate is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Kinnate Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Kinnate Biopharma stock prices may prove useful in developing a viable investing in Kinnate Biopharma
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. Kinnate Biopharma Inc. is a former subsidiary of Fount Therapeutics, LLC. Kinnate Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 82 people.

Kinnate Biopharma Stock Technical Analysis

Kinnate Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Kinnate Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Kinnate Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Bonds Directory Now

   

Bonds Directory

Find actively traded corporate debentures issued by US companies
All  Next Launch Module

Kinnate Biopharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Kinnate Biopharma's price direction in advance. Along with the technical and fundamental analysis of Kinnate Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Kinnate to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Consideration for investing in Kinnate Stock

If you are still planning to invest in Kinnate Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kinnate Biopharma's history and understand the potential risks before investing.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Stocks Directory
Find actively traded stocks across global markets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity